Software Engineer III
Cleerly
See how well this job matches your profile
Sign up to get an AI match score and generate a tailored application in seconds.
Get your match scoreTags
About the role
Role: Software Engineer III
Software Engineer III to drive key technical initiatives across Cleerly’s computational imaging pipeline. You’ll help own end-to-end regulated AI systems—deploying, scaling, and monitoring machine learning algorithms—while influencing architecture and mentoring engineers.
Responsibilities
- Build and deploy scalable AI services and computational imaging pipelines to production with high-availability infrastructure.
- Contribute to system architecture, making trade-offs across performance, security, and maintainability.
- Own full lifecycle delivery for complex features, from architectural planning and API design to implementation and post-release observability.
- Improve availability and observability: enhance alerting, logging, and incident response across the stack.
- Maintain strong engineering standards through code reviews, mentorship, and design documentation.
- Collaborate cross-functionally with AI and engineering to reduce knowledge silos via cross-training and documentation.
- Implement robust testing and validation strategies aligned with regulatory requirements and the Quality Management System.
Requirements
- Bachelor’s or Master’s in Computer Science, Software Engineering, or related field (or equivalent experience).
- 5–8 years of software engineering experience (posting provided up to this point).
Nice to have / Additional context
- Familiarity with Google Workspace (GMail, Drive, Docs, Sheets, Slides), Slack, and Confluence/Jira, and Zoom (prior experience is a plus).
- Travel may be required for team meetings/cross-functional projects (roughly monthly/quarterly); some roles could require up to 90% travel depending on external-facing needs (this role may vary).
About Cleerly
Cleerly is a healthcare company building AI-driven precision diagnostic solutions for heart disease. Its technology quantifies and characterizes atherosclerosis (plaque buildup) to support clinical trials and regulated medical products. The company operates as a remote-first organization with offices in the US and Lisbon and focuses on improving diagnosis, treatment, and tracking of heart disease.
Scraped 4/4/2026